ATE428724T1 - Immunreaktive peptide des epstein-barrvirus - Google Patents

Immunreaktive peptide des epstein-barrvirus

Info

Publication number
ATE428724T1
ATE428724T1 AT98113827T AT98113827T ATE428724T1 AT E428724 T1 ATE428724 T1 AT E428724T1 AT 98113827 T AT98113827 T AT 98113827T AT 98113827 T AT98113827 T AT 98113827T AT E428724 T1 ATE428724 T1 AT E428724T1
Authority
AT
Austria
Prior art keywords
epstein
barr virus
immunoreactive peptides
ebv
disclosed
Prior art date
Application number
AT98113827T
Other languages
English (en)
Inventor
Richard S Smith
Elliot D Parks
Gary R Pearson
Susan P Varghese
Original Assignee
Ortho Diagnostic Systems Inc
Univ Georgetown
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Diagnostic Systems Inc, Univ Georgetown filed Critical Ortho Diagnostic Systems Inc
Application granted granted Critical
Publication of ATE428724T1 publication Critical patent/ATE428724T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98113827T 1992-09-15 1993-09-15 Immunreaktive peptide des epstein-barrvirus ATE428724T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94528092A 1992-09-15 1992-09-15

Publications (1)

Publication Number Publication Date
ATE428724T1 true ATE428724T1 (de) 2009-05-15

Family

ID=25482904

Family Applications (2)

Application Number Title Priority Date Filing Date
AT93921588T ATE195950T1 (de) 1992-09-15 1993-09-15 Immunreaktive peptide des epstein-barrvirus
AT98113827T ATE428724T1 (de) 1992-09-15 1993-09-15 Immunreaktive peptide des epstein-barrvirus

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT93921588T ATE195950T1 (de) 1992-09-15 1993-09-15 Immunreaktive peptide des epstein-barrvirus

Country Status (11)

Country Link
EP (2) EP0671946B1 (de)
JP (2) JP3756944B2 (de)
AT (2) ATE195950T1 (de)
AU (1) AU693421B2 (de)
CA (1) CA2143642C (de)
DE (2) DE69334276D1 (de)
DK (1) DK0671946T3 (de)
ES (1) ES2149822T3 (de)
GR (1) GR3034972T3 (de)
PT (1) PT671946E (de)
WO (1) WO1994006470A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7326535B2 (en) 1993-09-15 2008-02-05 Ortho Diagnostic Systems Inc. Immunoreactive peptides from Epstein-Barr virus
US7060283B1 (en) 1992-09-15 2006-06-13 Ortho Diagnostic Systems, Inc. Immunoreactive peptides from Epstein-Barr virus
US6506553B1 (en) * 1995-03-30 2003-01-14 Ortho Diagnostics Systems, Inc. Method for diagnosis of Epstein-Barr virus associated disease
JP3618497B2 (ja) * 1996-12-27 2005-02-09 富士通株式会社 タンパク質の抗原決定基予測方法及びシステム
FR2791142B1 (fr) * 1999-03-17 2001-06-22 Univ Grenoble 1 Utilisation de la brefeldine a pour augmenter l'effet de presentation d'antigenes exogenes par les cpa
GB9916529D0 (en) * 1999-07-14 1999-09-15 Chiron Spa Antigenic peptides
EP2101177A1 (de) * 2008-03-10 2009-09-16 Universite Joseph Fourier Verwendung eines synthetischen Peptids aus dem ZEBRA-Protein für die in-vitro-Diagnose von Epstein-Barr-Virus (EBV)-Reaktivierung
EP3368092B9 (de) 2015-10-29 2020-07-29 Novartis AG Antikörperkonjugate mit toll-like-rezeptoragonist

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0173254B1 (de) * 1984-08-23 1991-07-24 Hans Joachim Wolf DNA-Sequenzen des EBV-Genoms, rekombinante DNA-Moleküle, Verfahren zur Herstellung von EBV-verwandten Antigenen sowie diagnostische Zusammensetzungen und pharmazeutische Zusammensetzungen, die die genannten Antigene enthalten
US4879213A (en) * 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
EP0585216A1 (de) * 1989-11-24 1994-03-09 The Council Of The Queensland Institue Of Medical Research Peptide gegen infektiöse mononukleose

Also Published As

Publication number Publication date
AU4922793A (en) 1994-04-12
WO1994006470A1 (en) 1994-03-31
AU693421B2 (en) 1998-07-02
DE69329347T2 (de) 2001-10-31
EP0671946A1 (de) 1995-09-20
DK0671946T3 (da) 2000-11-13
DE69334276D1 (de) 2009-05-28
ATE195950T1 (de) 2000-09-15
EP0671946A4 (de) 1995-11-29
JPH08510714A (ja) 1996-11-12
EP0889052A3 (de) 1999-08-18
CA2143642C (en) 2006-09-05
JP3757220B2 (ja) 2006-03-22
CA2143642A1 (en) 1994-03-31
DE69329347D1 (de) 2000-10-05
EP0889052B1 (de) 2009-04-15
JP3756944B2 (ja) 2006-03-22
PT671946E (pt) 2000-12-29
GR3034972T3 (en) 2001-02-28
EP0671946B1 (de) 2000-08-30
ES2149822T3 (es) 2000-11-16
EP0889052A2 (de) 1999-01-07
JP2004057208A (ja) 2004-02-26

Similar Documents

Publication Publication Date Title
PT725824E (pt) Epitopos de celulas t humanas imunodominantes do virus da hepatite c
LU91400I2 (fr) "La protéine L1 recombinante du papillomavirus humain de type 18" Gardasil-Silgard
EP0357750A4 (en) Urethane-protected amino acid-n-carboxyanhydrides
DE59209921D1 (de) Seroreaktive Bereiche auf den HPV 16 Proteinen E1 und E2
DE69532996D1 (de) Peptidanaloge des menschlichen basischen myelinproteins
ATE348113T1 (de) Rekombinanter anti-cd4 antikörper zur menschlichen behandlung
EP0832105A4 (de) Immunogene peptide des prostata spezifischen antigens
ATA257190A (de) Virales polypeptid
PL322333A1 (en) Dna encoding human papilloma viruses of type 18
ATE195950T1 (de) Immunreaktive peptide des epstein-barrvirus
DE69534325D1 (de) Peptide zur behandlung von krebs
ATE201693T1 (de) Hämoregulierende peptide
FI942184L (fi) Epstein-Barr-viruksen peptidejä ja näitä peptidejä vastaan suunnattuja vasta-aineita
ATE356144T1 (de) Regulatorische/entfaltende peptide von ezrin
DE59109235D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
DE59710091D1 (de) Von Kaposi-sarkom assoziiertem Herpes-Virus (KSHV, HHV-8) kodiertes Polypeptid und dessen Verwendung in Diagnostik und Therapie
GB9425604D0 (en) Peptides effective for diagnsis of hepatitis C infection
KR950702244A (ko) 백신으로서의 즉석 초기 hsv-2 비루스 단백질 icp27(immediatie early hsv-2 viral protein icp27 as vaccine)
DE69328488D1 (de) Peptide, analoge und ihre mischungen zur detektion und erzeugung von antikörpern gegen die e1 und e2 proteine des rubella virus
IT9019699A0 (it) Procedimento di purificazione del b-interferone umano ricombinante
DE69420044D1 (de) Blutregulierende peptide
AU635124B2 (en) Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines
IT8944004A0 (it) Procedimento per l'impianto di trattamento totale dei fumi provenienti da processi di combustione
DE69739115D1 (de) Immunogenes hla-bindendes peptid und verwendung desselben zur hiv-infektionsbehandlung
AU646275C (en) Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties